Apimeds Pharmaceuticals US APUS
NYSE APUS
$3.20 -0.21 (-6.14%)
As of: Oct 21, 2026 · 3:59 PM EDT

Apimeds Pharmaceuticals US (APUS) Other non-cash items (2024 - 2025)

Updated

Analysis

Apimeds Pharmaceuticals US (APUS) Other non-cash items (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Apimeds Pharmaceuticals US 5.44 Mn -14.20 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 243,177.00
Sep 30, 2025 -12,859.00
Jun 30, 2025 -9,518.00
Mar 31, 2025 26,776.00
Dec 31, 2024 62,618.00
Sep 30, 2024 22,530.00
Jun 30, 2024 13,619.00
Mar 31, 2024 18,952.00
API Access

Apimeds Pharmaceuticals US Other non-cash items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=APUS&period=max&api_key=YOUR_API_KEY